RNAi-mediated suppression of the mitochondrial iron chaperone, frataxin, in Drosophila.
The mitochondrial iron chaperone, frataxin, plays a critical role in cellular iron homeostasis and the synthesis and regeneration of Fe-S centers. Genetic insufficiency for frataxin is associated with Friedreich's Ataxia in humans and confers loss of function of Fe-containing proteins including components of the respiratory chain and mitochondrial and cytosolic aconitases. Here, we report the use of RNA-interference (RNAi) to suppress frataxin in the multicellular eukaryote, Drosophila. Phenotypically, suppression of the Drosophila frataxin homologue (dfh) confers distinct phenotypes in larvae and adults, leading to giant long-lived larvae and to conditional short-lived adults. Deficiency of the DFH protein results in diminished activities of numerous heme- and iron-sulfur-containing enzymes, loss of intracellular iron homeostasis and increased susceptibility to iron toxicity. In parallel with the differential larval and adult phenotypes, our results indicate that dfh silencing differentially dysregulates ferritin expression in adults but not in larvae. Moreover, silencing of dfh in the peripheral nervous system, a specific focus of Friedreich's pathology, permits normal larval development but imposes a marked reduction in adult lifespan. In contrast, dfh silencing in motorneurons has no deleterious effect in either larvae or adults. Finally, overexpression of Sod1, Sod2 or Cat does not suppress the failure of DFH-deficient animals to successfully complete eclosion, suggesting a minimal role of oxidative stress in this phenotype. The robust developmental, biochemical and tissue-specific phenotypes conferred by DFH deficiency in Drosophila provide a platform for identifying genetic, nutritional and environmental factors, which ameliorate the symptoms arising from frataxin deficiency.
Anderson
Peter R
PR
Department of Molecular and Cellular Biology, University of Guelph, Ontario, Canada.
Kirby
Kim
K
Hilliker
Arthur J
AJ
Phillips
John P
JP
D000595:Amino Acid Sequence; D000818:Animals; D049628:Body Size / Q000235:genetics; D002374:Catalase / Q000502:physiology; D003600:Cytosol / Q000378:metabolism; D029721:Drosophila Proteins / Q000037:antagonists & inhibitors* / Q000235:genetics; D004331:Drosophila melanogaster / Q000235:genetics* / Q000254:growth & development / Q000378:metabolism*; D005260:Female; D020868:Gene Silencing; D006801:Humans; D007501:Iron / Q000378:metabolism*; D033862:Iron-Binding Proteins / Q000037:antagonists & inhibitors* / Q000235:genetics; D007506:Iron-Sulfur Proteins / Q000378:metabolism; D007814:Larva / Q000235:genetics / Q000254:growth & development / Q000378:metabolism; D008297:Male; D008928:Mitochondria / Q000378:metabolism*; D008969:Molecular Sequence Data; D009474:Neurons / Q000378:metabolism; D017853:Phosphotransferases (Alcohol Group Acceptor) / Q000037:antagonists & inhibitors* / Q000235:genetics; D011679:Pupa / Q000235:genetics / Q000254:growth & development / Q000378:metabolism; D034622:RNA Interference / Q000502:physiology*; D013482:Superoxide Dismutase / Q000502:physiology; D000072105:Superoxide Dismutase-1; D019076:Transgenes; D000096923:Frataxin; D000099156:Superoxide Dismutase 2
D002374:Catalase; D029721:Drosophila Proteins; D007501:Iron; D033862:Iron-Binding Proteins; D007506:Iron-Sulfur Proteins; D017853:Phosphotransferases (Alcohol Group Acceptor); D013482:Superoxide Dismutase; D000072105:Superoxide Dismutase-1; D000096923:Frataxin; D000099156:Superoxide Dismutase 2; C000606290:SOD1 protein, human; C417943:dfk protein, Drosophila